By Editor , 27 October 2026
Truveta Data: 40% of Early Foundayo Users Had No Prior GLP-1 Use

United States – October 27, 2026 -- An analysis of 5,723 patients on Foundayo (oral orforglipron) found that 40.3% had no evidence of prior GLP-1 medication use, according to Truveta, which is pitching real-time "healthcare intelligence" to life science, healthcare and government teams.

Foundayo uptake runs mostly through primary care

Truveta researchers used Truveta Data to identify patients with a Foundayo prescription or medication dispense between April 1 and July 6, 2026. The drug was approved for obesity in April 2026.

By Editor , 27 October 2026
China leads 16-nation electrification index as US risks stalling

LONDON – October 27, 2026 -- China holds the highest electrification deployment score among 16 countries assessed in a new index, while the US risks losing momentum and several large European economies have yet to turn policy into delivery.

By Editor , 27 October 2026
Auto Co-Op Ad Spending Climbs as Dealer Inventories Grow

Global – October 27, 2026 -- Co-op advertising spending in the auto industry is rising as growing vehicle inventories push manufacturers to underwrite dealer marketing and move units off the lot.

Manufacturers fund more local dealer campaigns amid market share competition

Under co-op programs, manufacturers cover part of the cost of dealership campaigns across digital, print, TV, radio and events. Competition for local market share adds to the spending increase, according to the source.

By Editor , 27 October 2026
Identical +15 eNPS Scores Can Hide Very Different Workforces

Global – October 27, 2026 -- An Employee Net Promoter Score (eNPS) of +15 can conceal a shrinking pool of promoters, a growing block of detractors and a falling response rate, according to an Alteryx guide on employee engagement reporting for HR and employee experience (EX) teams.

By Editor , 27 October 2026
Spreadsheet Errors Cost Firms $12.9M a Year, Gartner Estimates

Global – October 27, 2026 -- Poor data quality costs organizations an average of $12.9 million a year, according to Gartner estimates cited in an Alteryx analysis that frames recurring, multi-source reporting as the point where Excel stops being the right tool.

By Editor , 27 October 2026
McKinsey: Only 14% of AI Adopters Cut Staff as Finance Roles Hold

United States – October 27, 2026 -- Only 14% of organizations using AI say it reduced their total workforce in the past year, down from the 32% that expected cuts a year earlier, according to McKinsey's State of AI 2026. Two-thirds report little or no AI-related change in employment.

Inside finance, Deloitte found that 84% of finance organizations have yet to redesign jobs or the nature of work around AI. AI is therefore landing on finance teams that look much like they did before.

By Editor , 27 October 2026
Finance Chiefs Own Both AI Cost and AI Trust, Deloitte Survey Finds

NORTH AMERICA – October 27, 2026 -- Finance leaders now answer for both AI trust and AI spending. In Deloitte's Finance Trends 2027 survey of more than 1,400 finance leaders, 48% oversee AI trust, covering the reliability, accuracy and explainability of AI output, and 48% manage AI spending and cost controls. More than two-thirds of the leaders holding these responsibilities took them on within the past three years.

By Editor , 26 October 2026
Six Document360 Alternatives Target Service, Collaboration Gaps

Global – October 25, 2026 -- Six platforms (KMS Lighthouse, Confluence, Guru, Zendesk Knowledge, eGain Knowledge Hub and Helpjuice) are being positioned as alternatives to Document360 for organizations whose knowledge needs have outgrown structured documentation.

By Editor , 25 October 2026
Morgan Stanley Sizes DTC Cash-Pay Biopharma Market at $26B Peak

United States – October 24, 2026 -- The direct-to-consumer cash-pay market in biopharma could reach $26 billion at its peak, according to Morgan Stanley healthcare services analyst Erin Wright, as U.S. patients take more control over how they access and pay for care.

By Editor , 25 October 2026
ARM Readies First In-House Chip as Intel Strategy Faces Doubt

Global – October 24, 2026 -- ARM is set to debut its first in-house chip by summer, moving beyond its traditional role as an IP provider into chip design, while Intel's strategy as an integrated device manufacturer (IDM) faces questions after CEO Pat Gelsinger departed in December 2024.